America is making headway against heart disease, with heart-related deaths declining over the past three decades. But it appears that only the well-to-do have benefitted, a new study shows. Heart attack rates have stayed the same or gotten worse among the poor during the same 30-year period, researchers found. “The decline in cardiovascular health has… read on > read on >
Obese folks are less likely to benefit from a nerve-stimulation treatment for sleep apnea that’s recently been made available to them, a new study reports. The treatment is likely to be 75% less effective among obese people with BMIs of 32 to 35, compared to patients with lower BMIs, researchers found. “Our study shows that… read on > read on >
People with Long COVID might be able to exercise to improve their health, something that up to now has been discouraged, a new study suggests. “The World Health Organization [WHO] and other major bodies have said that people with post-COVID should avoid intense exercise,” said lead researcher Andrea Tryfonos, a postdoctoral investigator with the Karolinska… read on > read on >
Suicides among U.S. college athletes have doubled over the past two years, according to data from the National Collegiate Athletic Association (NCAA). Suicide is now the second most common cause of death for college athletes after accidents, results show. “Athletes are generally thought of as one of the healthiest populations in our society, yet the… read on > read on >
Overuse of marijuana is increasingly being linked to dangerous bouts of psychosis, and a new study finds that antipsychotics may be needed to keep such patients out of the hospital. Psychotic episodes involve a dangerous psychiatric state in which people lose their connection with reality. These episodes can get so out of control that people… read on > read on >
A test to gauge if it’s safe to prescribe a patient an addictive opioid may have been approved too soon by the U.S. Food and Drug Administration, claims a letter sent to the agency by a group of experts. The test, called AvertD, is meant to screen for genetic markers suggesting that a person has… read on > read on >
THURSDAY, April 4, 2024 (HealthDayNews) — Following disappointing trial results, the maker of a controversial ALS drug said it is pulling the medication off the market. In a statement issued Thursday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a large follow-up study, and the drug “will no longer be available for new… read on > read on >
Childbirth is a harrowing ordeal, and it’s being made worse by mistreatment from health care providers during labor, a new study says. More than one in every eight women are mistreated during childbirth, researchers found. Most commonly, women’s requests for help during labor were refused or ignored, results show. Nearly 8% of women said this… read on > read on >
Rick Slayman, the first person to receive a kidney transplant from a genetically modified pig, headed home Wednesday after faring so well that he was released from the hospital just two weeks after his groundbreaking surgery. “This moment — leaving the hospital today with one of the cleanest bills of health I’ve had in a… read on > read on >
A good night’s sleep is often hampered by caffeine, hunger, alcohol or chronic pain. Now, America has a new cause of poor sleep: the sound of gunfire on city streets. New research shows that gunshots are twice as likely to occur at night, mostly affecting the sleep of people in low-income neighborhoods. In fact, nearly… read on > read on >
